Status:
UNKNOWN
Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Postpartum Depression
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Rationale and Hypotheses of the Current Research: the investigators speculate that mothers suffering from PPD exhibit high levels of depression and low levels of OXT, hence experiencing the interactio...
Eligibility Criteria
Inclusion
- Women of all ages who are 3 to 8 months post-partum.
- Women who have completed a minimum of 12 years of education.
- Women who are willing and able to provide informed consent for their participation and after the study has been explained. Infant participation will be allowed after consent has been obtained from mothers.
- Current DSM-IV-TR diagnosis of PPD disorder as confirmed by SCID (administered as part of the study of protocol number PPD1, proposed to the Helsinki committee on June 2014).
- Symptoms: BDI total score \>9, EPDS total score \>10
- Treatment with antidepressants will be allowed provided that patients have been on the medication for at least 4 weeks prior to entry into the pre-treatment assessment phase of the study.
Exclusion
- Unwilling or unable, in the opinion of the investigator, to comply with study instructions.
- Pregnant women.
- Clinically significant medical disease (malignancy, poorly controlled diabetes, active ischemic cardiac disease, or cardiomyopathy, serious pulmonary disease, kidney disease, impaired liver functioning).
- Women with significant risk of committing suicide or harming others in the opinion of the psychiatrist.
- Women with a current DSM-IV-TR substance or alcohol abuse. However, patients with a history of and/or current recreational use of cannabinoids or alcohol, and/or patients who smoke cigarettes can be included.
- Women who suffers from depression due to physical condition.
- Women who suffers from severe major depression (MADRAS\>30)
- Women who suffers from chronic depression (over 6 months)
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02191423
Start Date
January 1 2015
Last Update
July 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel